0.886
-0.15 (-14.84%)
| Penutupan Terdahulu | 1.04 |
| Buka | 1.05 |
| Jumlah Dagangan | 3,426,509 |
| Purata Dagangan (3B) | 11,127,206 |
| Modal Pasaran | 16,338,600 |
| Harga / Jualan (P/S) | 95.69 |
| Harga / Buku (P/B) | 9.33 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Aug 2025 |
| EPS Cair (TTM) | -0.800 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 5.05% |
| Nisbah Semasa (MRQ) | 4.86 |
| Aliran Tunai Operasi (OCF TTM) | -5.51 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -2.99 M |
| Pulangan Atas Aset (ROA TTM) | -78.05% |
| Pulangan Atas Ekuiti (ROE TTM) | -141.43% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Health Information Services (US) | Menurun | Bercampur |
| Health Information Services (Global) | Menurun | Bercampur | |
| Stok | Bullfrog AI Holdings, Inc. | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | -2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 0.5 |
| Purata | -0.25 |
|
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. The Company is focused specifically on advance artificial intelligence and machine learning (AI/ML)- driven analysis of complex datasets in medicine and healthcare. The Company's objective is to use its AI/ML platform to provide a precision-medicine approach to drug-asset enablement through external partnerships and selective internal development. |
|
| Sektor | Healthcare |
| Industri | Health Information Services |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 25.43% |
| % Dimiliki oleh Institusi | 4.51% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 04 Feb 2026 | Pengumuman | BullFrog AI to Unveil New Precision AI Capability |
| 27 Jan 2026 | Pengumuman | BullFrog AI on Data Harmonization: The Hidden Prerequisite for Reliable AI/ML in Life Sciences |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |